XBiotech Inc (NASDAQ: XBIT) stock enjoyed a major increase of 12.2% on 3/18/24. The shares closed at $6.63. Moreover, trading volume in this advance was exceptionally high at 232% of normal. The stock has risen 3.6% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, XBIT is expected to continue to be Value Creation neutral.
XBiotech has a current Value Trend Rating of D (Negative). This VT Rating improved modestly in recent days from F previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. XBiotech has a neutral Power Rating of 47 but a poor Appreciation Score of 25, leading to the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment